THE INVENTION RELATES TO THE F-CRYSTAL FORM, G-CRYSTAL FORM, H-CRYSTAL FORM, I-CRYSTAL FORM AND 5 K-CRYSTAL FORM OF THE METHANESULFONIC ACID ADDITION SALT OF 4-(4-METHYLPIPERAZIN-1-YLMETHYL)- N-[4-METHYL-3-(4-(PYRIDIN-3-YL)PYRIMIDIN-2-YLAMINO)PHENYL]-BENZAMIDE, CERTAIN PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE CRYSTAL FORMS, THEIR USE IN DIAGNOSTIC METHODS OR FOR THE THERAPEUTIC TREATMENT OF WARM-BLOODED ANIMALS, AND THEIR USE AS AN INTERMEDIATE OR FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS FOR USE IN DIAGNOSTIC METHODS OR FOR THE THERAPEUTIC TREATMENT OF WARM-BLOODED ANIMALS, ESPECIALLY HUMANS.
